Presented Updated Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presented updated data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presented Updated Data Today - Breaking & Trending Today

Innovative Cellular Therapeutics (ICT) Presented Updated Data of the China-IRB Study of GCC19CART in Metastatic Colorectal Cancer at European Society for Medical Oncology (ESMO) Congress 2023

Innovative Cellular Therapeutics (ICT) Presented Updated Data of the China-IRB Study of GCC19CART in Metastatic Colorectal Cancer at European Society for Medical Oncology (ESMO) Congress 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lucy Lu , Company Coupled , Company Phase , Innovative Cellular Therapeutics Inc , European Society For Medical Oncology , Cellular Therapeutics , Presented Updated Data , Metastatic Colorectal Cancer , European Society , Medical Oncology , Escalation Study , Metastatic Colorectal , Chief Operations Officer , Relations Contacts ,

Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results


Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., March 12, 2021 /PRNewswire/  Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2020.
2020 Leap Highlights:
Signed agreement with BeiGene, Ltd. for rights to Leap s anti-DKK1 antibody, DKN-01, in Asia (excluding Japan), Australia and New Zealand
Completed a $51.75 million public offering of common stock and pre-funded warrants to purchase common stock
Presented updated data from study of DKN-01 plus pembrolizumab in esophagogastric (EGC) cancer demonstrating positive outcomes in DKK1-high patients ....

New Zealand , United States , United Kingdom , Douglase Onsi , Heather Savelle , Society For Immunotherapy Of Cancer , Beigene Ltd , Biology Driving Research , American Association For Cancer Research , Securities Exchange , Leap Therapeutics Inc , Society Of Gynecologic Oncology , Leap Therapeutics , Orphan Drug Designation , Fast Track Designation , Chief Executive Officer , Beigene Announced First Patient Dosed , Gastroesophageal Junction , Presented Updated Data , Positive Outcomes , Anniversary Annual Meeting , Biomarker Selected Patients , American Association , Cancer Research , Virtual Special Conference , Endometrial Cancer ,